Categories: Business

Keeping SARS-CoV-2 closed for business with small molecules – Science Daily

The infamous spike proteins on the surface of SARS-CoV-2 help it bind to and enter human cells. Because of their important role in spreading infection, these spike proteins are one of the main targets for COVID-19 vaccines and treatments. But those remedies gradually lose effectiveness when certain segments of the spike proteins mutate. Now, researchers report that they have discovered small molecules that successfully target other segments that mutate less.

Spike proteins change shape when they attack a cell. In their “open” structure, they expose a section known as the receptor-binding domain (RBD) so it can attach to the ACE2 protein on human cells. In the “closed” structure, this RBD segment is tucked inside the spike protein and can’t bind to human cells. Antibodies contained in some COVID-19 therapies or stimulated by vaccines or infection target the RBD domain so it can’t bind to ACE2. However, some emerging variants of the coronavirus contain mutations in the RBD fragment. That means vaccines and antibody therapies designed to target that fragment could become less effective as the virus mutates.

To get around this problem, other, less mutation-prone parts of the spike protein could be targeted instead. One possibility is a pocket in the spike protein that has been dubbed the Achilles’ heel of the virus. When this cranny is occupied by free fatty acids (FFAs) or a few other compounds, the protein remains locked in its closed, harmless configuration. However, those compounds aren’t suitable treatments because they aren’t stable or they bind weakly. So, Jianhui Huang, Niu Huang and colleagues decided to look for other potential treatments that lack these flaws.

Using computer modeling, the team screened a library of small molecules, seeking ones that could slip into this pocket and stick firmly to the spike protein, keeping it in the closed shape. The researchers then used surface plasmon resonance and other techniques to evaluate analogs of these molecules for improved binding and solubility. The resulting compounds, which can bind to spike proteins from the original coronavirus as well as the omicron BA.4 variant, could serve as a starting point for developing broad-spectrum treatments for COVID-19, the team says.

The authors acknowledge support from the Beijing Municipal Science & Technology Commission and Tsinghua University.

source

InfoLair

Our primary beliefs and values include giving our readers quality material, disseminating information to encourage informed thinking, and supporting policies and ideas. We frequently curate or extract content from reliable online sources in order to uphold those ideals.

Recent Posts

Boston Public Library Hosting Several Drag Queen Makeup Tutorials For Teens This Month – NewBostonPost

Boston Public Library Hosting Several Drag Queen Makeup Tutorials For Teens This Month  NewBostonPost Source Read More

2 days ago

Miss World 2025: Krishnah Gravidez enters Top 8 – Inquirer.net

Miss World 2025: Krishnah Gravidez enters Top 8  Inquirer.netKrishnah Gravidez ends Miss World 2025 journey, finishes… Read More

4 days ago

Burger King just came out with a 'How to Train Your Dragon' meal with toys, how to order – Fall River Herald News

To read the full article click below: Burger King just came out with a 'How… Read More

5 days ago

DIY automation isn’t always a win: What mortgage lenders need to know – housingwire.com

To read the full article click below: DIY automation isn’t always a win: What mortgage… Read More

1 week ago

Butter Yellow Is Taking Over Makeup Tutorials on TikTok After Years of Trending in Fashion – L'OFFICIEL USA

Butter Yellow Is Taking Over Makeup Tutorials on TikTok After Years of Trending in Fashion  L'OFFICIEL… Read More

1 week ago

Four men guilty of Kim Kardashian jewellery heist in Paris – The Guardian

Four men guilty of Kim Kardashian jewellery heist in Paris  The GuardianRobbery gang guilty of Kim… Read More

2 weeks ago

This website uses cookies.